Anti-POTEH antibody
| Name | Anti-POTEH antibody |
|---|---|
| Supplier | Abcam |
| Catalog | ab88111 |
| Prices | $370.00 |
| Sizes | 50 µg |
| Host | Mouse |
| Clonality | Monoclonal |
| Isotype | IgG2a |
| Applications | WB ELISA ICC/IF |
| Species Reactivities | Human |
| Antigen | Recombinant fragment: VPRKDLIVML KDTDMNKKDK QKRTALHLAS ANGNSEVVKL LLDRRCQLNV LDNKKRTALT KAVQCQEDEC ALMLLEHGTD PNIPDEYGNT ALHYAIYNED , corresponding to amino acids 189-289 of Human POTEH with proprietary tag (NP_001004053) |
| Description | Mouse Monoclonal |
| Gene | POTEH |
| Conjugate | Unconjugated |
| Supplier Page | Shop |
Product images
Product References
The C-terminal common to group 3 POTES (CtG3P): a newly discovered nucleolar - The C-terminal common to group 3 POTES (CtG3P): a newly discovered nucleolar
Redfield SM, Mao J, Zhu H, He Z, Zhang X, Bigler SA, Zhou X. Am J Cancer Res. 2013 Jun 20;3(3):278-89. Print 2013.
POTEH hypomethylation, a new epigenetic biomarker for glioma prognosis. - POTEH hypomethylation, a new epigenetic biomarker for glioma prognosis.
Liu X, Tang H, Zhang Z, Li W, Wang Z, Zheng Y, Wu M, Li G. Brain Res. 2011 May 19;1391:125-31.
POTEH hypomethylation, a new epigenetic biomarker for glioma prognosis. - POTEH hypomethylation, a new epigenetic biomarker for glioma prognosis.
Liu X, Tang H, Zhang Z, Li W, Wang Z, Zheng Y, Wu M, Li G. Brain Res. 2011 May 19;1391:125-31.
POTEH hypomethylation, a new epigenetic biomarker for glioma prognosis. - POTEH hypomethylation, a new epigenetic biomarker for glioma prognosis.
Liu X, Tang H, Zhang Z, Li W, Wang Z, Zheng Y, Wu M, Li G. Brain Res. 2011 May 19;1391:125-31.